Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
Authors
Keywords
Lung and intrathoracic tumors, Cancer screening, Death rates, Forecasting, Computed axial tomography, Cancer detection and diagnosis, Smoking habits, Health screening
Journal
PLOS MEDICINE
Volume 11, Issue 12, Pages e1001764
Publisher
Public Library of Science (PLoS)
Online
2014-12-03
DOI
10.1371/journal.pmed.1001764
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lung Cancer Screening
- (2017) Douglas E. Wood et al. Journal of the National Comprehensive Cancer Network
- When the Average Applies to No One: Personalized Decision Making About Potential Benefits of Lung Cancer Screening
- (2013) Peter B. Bach et al. ANNALS OF INTERNAL MEDICINE
- Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer
- (2013) Olaide Y. Raji et al. ANNALS OF INTERNAL MEDICINE
- American Cancer Society lung cancer screening guidelines
- (2013) Richard Wender et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Screening High-Risk Populations for Lung Cancer: Guideline Recommendations
- (2013) Heidi Roberts et al. Journal of Thoracic Oncology
- Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death
- (2013) Stephanie A. Kovalchik et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selection Criteria for Lung-Cancer Screening
- (2013) Martin C. Tammemägi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
- (2013) Annette McWilliams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Computed Tomographic Screening for Lung Cancer
- (2013) Phillip M. Boiselle et al. JAMA Internal Medicine
- From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue française (GOLF)
- (2012) S. Couraud et al. ANNALS OF ONCOLOGY
- Benefits and Harms of CT Screening for Lung Cancer
- (2012) Peter B. Bach et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups
- (2012) Michael T. Jaklitsch et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Screening by Chest Radiograph and Lung Cancer Mortality
- (2011) Martin M. Oken et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Baseline Characteristics of Participants in the Randomized National Lung Screening Trial
- (2010) et al. JNCI-Journal of the National Cancer Institute
- The National Lung Screening Trial: Overview and Study Design
- (2010) RADIOLOGY
- Lung Cancer in Never Smokers: Clinical Epidemiology and Environmental Risk Factors
- (2009) J. M. Samet et al. CLINICAL CANCER RESEARCH
- Factors associated with non-participation and drop-out in a lifestyle intervention for workers with an elevated risk of cardiovascular disease
- (2009) Iris F Groeneveld et al. International Journal of Behavioral Nutrition and Physical Activity
- Lung Cancer Occurrence in Never-Smokers: An Analysis of 13 Cohorts and 22 Cancer Registry Studies
- (2008) Michael J Thun et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started